These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35200603)

  • 81. Small bowel nonendocrine neoplasms: current concepts and novel perspectives.
    Piscaglia AC; Campanale M; Gasbarrini G
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):320-6. PubMed ID: 20496542
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.
    Overman MJ; Kopetz S; Wen S; Hoff PM; Fogelman D; Morris J; Abbruzzese JL; Ajani JA; Wolff RA
    Cancer; 2008 Oct; 113(8):2038-45. PubMed ID: 18759326
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Malignant tumours of the small bowel.
    Donohue JH
    Surg Oncol; 1994 Apr; 3(2):61-8. PubMed ID: 7952393
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Gulhati P; Raghav K; Shroff RT; Varadhachary GR; Kopetz S; Javle M; Qiao W; Wang H; Morris J; Wolff RA; Overman MJ
    Cancer; 2017 May; 123(6):1011-1017. PubMed ID: 27859010
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma.
    Sacdalan DB; Mendoza MJ; Vergara JP; Catedral LI; Ting FI; Leones LM; Berba CM; Sacdalan DL
    Med Oncol; 2020 Nov; 37(11):106. PubMed ID: 33135102
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Enhancing treatment strategies for small bowel cancer: a clinical review of targeted therapy and immunotherapy approaches.
    Ebrahimpour M; Hosseinzadeh H; Abedi F; Nodeh MM; Allahyari A; Sahebkar A; Arasteh O
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4601-4614. PubMed ID: 38329524
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinicopathological features and treatment outcomes of metastatic or locally unresectable small bowel adenocarcinoma.
    Li X; Ying H; Cheng Y; Zhao L; Zhao S; Bai C; Zhou J
    J BUON; 2019; 24(6):2539-2545. PubMed ID: 31983130
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
    Makino S; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Yamamoto H; Doki Y; Mori M; Mizushima T
    Anticancer Res; 2017 Mar; 37(3):1495-1500. PubMed ID: 28314324
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Tumors of the small intestine].
    Gräter H
    Praxis (Bern 1994); 2002 Oct; 91(41):1699-704. PubMed ID: 12422774
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical Features, Management, and Molecular Characteristics of Familial Small Bowel Neuroendocrine Tumors.
    Lim JY; Pommier RF
    Front Endocrinol (Lausanne); 2021; 12():622693. PubMed ID: 33732215
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Small bowel adenocarcinoma: Case reports and review of the literature.
    Manley J; Ibrahim Y; Ansell J; Alastal H; Rasheed A
    Arab J Gastroenterol; 2021 Sep; 22(3):240-245. PubMed ID: 34531134
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Small bowel adenocarcinoma: understaged and undertreated?
    Nicholl MB; Ahuja V; Conway WC; Vu VD; Sim MS; Singh G
    Ann Surg Oncol; 2010 Oct; 17(10):2728-32. PubMed ID: 20458546
    [TBL] [Abstract][Full Text] [Related]  

  • 93. What are the latest pharmacotherapy options for small bowel adenocarcinoma?
    Ynson ML; Senatore F; Dasanu CA
    Expert Opin Pharmacother; 2014 Apr; 15(6):745-8. PubMed ID: 24588646
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
    Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
    Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Updates in the diagnosis and management of small-bowel tumors.
    Vlachou E; Koffas A; Toumpanakis C; Keuchel M
    Best Pract Res Clin Gastroenterol; 2023; 64-65():101860. PubMed ID: 37652650
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995.
    Howe JR; Karnell LH; Menck HR; Scott-Conner C
    Cancer; 1999 Dec; 86(12):2693-706. PubMed ID: 10594865
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Progression of diagnosis and treatment in primary malignant small bowel tumor].
    Zhao Z; Guan X; Chen Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):117-120. PubMed ID: 28105627
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A case report of small bowel adenocarcinoma with liver metastases: genetic profiling and clinical management.
    Ali WAS; Liu W; Xiao Y; Fang J; Xu Q
    Transl Cancer Res; 2019 Aug; 8(4):1624-1629. PubMed ID: 35116906
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.
    Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
    Nutr Cancer; 2016 Jul; 68(5):750-5. PubMed ID: 27282771
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients.
    Simon M; Cosnes J; Gornet JM; Seksik P; Stefanescu C; Blain A; Pariente B; Nancey S; Vuitton L; Nachury M; D'Haens G; Filippi J; Chevret S; Laharie D;
    J Crohns Colitis; 2017 Jan; 11(1):47-52. PubMed ID: 27405958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.